FDA Intelligence | FDA

Advertising and Promotion

Jul 27, 2020
Bad Ad Program At 10
Jul 16, 2020
New Normal Means Changes in Sales Rep. Visits, Promotional Material
May 13, 2020
COVID-19 Changes Medical Product Marketing Fundamentally
Apr 17, 2020
Move to Telemedicine Will Change Promotion Approaches
Mar 15, 2020
OPDP Shows Concern About Lack of Risk Information in Electronic Communications
Feb 4, 2020
Industry Needs To Watch OPDP Research’s Impact on Policy
Jan 7, 2020
FDA’s New CURE ID Program Could Affect Wide Spectrum of Off-label Issues
Dec 6, 2019
Trends Seen in 2019 OPDP Enforcement Letters
Nov 15, 2019
Untitled Letter Provides Reminder of Rules for Patient Testimonials
Oct 6, 2019
Does Recent Warning Letter Indicate OPDP Plans More Aggressive Enforcement?

Good Clinical Practice

Food Labeling

FDA Regulation & Enforcement

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.